Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

John HoodTech Achievers-A HTA.TODON'T BUYJun 29, 2023

HTA vs. ZQQ

He'd be more cautious of HTA, because if he's going to take the risk of tech, he wants to have the full growth potential of that and not be somewhat coralled by covered calls. On tech, he'd be doing ZQQ.

$14.94

Stock price when the opinion was issued

$22.90

As of Jun 19, 2026. Market Open.

0
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY ON WEAKNESS

Growth and income for large tech companies.
Very strong performance. 
Wait to buy when price falls. 
Not a good short term investment.
Need to wait a long time for investment.


BUY

They pick up major tech stocks and write options on them. Harvest ETFs are good with yield, though not growth. Overall, it's fine.

DON'T BUY
He's fairly underweight the tech space. Underperformed the broader market. High yield of 9% or so, but total return hasn't done well. You don't want to be in tech in this part of the cycle. Beyond the first few names, the stocks are expensive. Visibility of earnings and revenue from the smaller-cap names is a bit tougher as well.
BUY
Tech & Health Care. If you are going to own one you might as well own both of them. Both are mega caps. These are covered written to get extra income (yield). He would say to go with health care in this case, however, if not both.
COMMENT

Most Harvest ETFs pay a very good yield, because they do the covered call overlay, but some of the charts are choppy. You'd be better off with ZQQ-T. Do you want the straight growth or a covered call?

COMMENT

Harvest is pretty new to ETF space. Takes the best known companies and adds covered call. Problem is that covered calls will most always be outperformed by the companies themselves. Covered calls are great for generating tax-efficient income, but not growth.